All tenders

The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentinel System

Ref US-FDARFI10282022Advertised01 Nov 2022Closing 12 Dec 2022

Tender Description

Notice type: Special Notice · NAICS 54171 · PSC B537 · Place of performance: Silver Spring, MD The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform the future organization of the Sentinel System. FDA seeks information that will assist in the exploration of alternative approaches to meet FDA’s legal requirements and fulfill its public health mission by adding value to the Sentinel System. Specifically, FDA is interested in organizational capabilities that will support the development of an efficient and economical product safety surveillance system that is not limited to the use of a common data model and a distributed data partners network and instead leverages multiple technical approaches. See Attachment for RFI.

Country
United States
Published
01 Nov 2022
Closing date
12 Dec 2022
Procedure
Special Notice
Predictive Analytics
Notice sources
Tender updates

Update history (1)

Field-level amendments detected by TenderHive monitoring at each harvest of the source portal.

  1. us_samgov2 fields changed
    • Scope of works

      Notice type: Special Notice · NAICS 54171 · PSC B537 · Place of performance: Silver Spring, MD The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform th…

      Notice type: Special Notice · NAICS 54171 · PSC B537 · Place of performance: Silver Spring, MD The Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER) requests public comments to inform th…

    • Source notice URL

      https://sam.gov/opp/4ca6bfd7de07401d8d818d0bf337f472/view

      https://sam.gov/opp/aae512f635c746dd9b2669b7f6951fb6/view